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Objective: The aim of the study was to investigate the correlation between the subjective symptoms and
parameters of urodynamic and imaging studies in male patients with non-neurogenic overactive bladder
(OAB).
Materials and methods: We prospectively recruited male patients with OAB between January 2008 and
June 2012. Patients with neurological comorbidities were excluded. We used the International Prostate
Symptom Score (IPSS) and the Overactive Bladder Symptom Score (OABSS) to evaluate subjective
symptoms. All patients underwent pressure-ﬂow urodynamic studies. All patients received trans-
abdominal ultrasound, which provided the information about intravesical prostatic protrusion (IPP),
prostate volume, and detrusor wall thickness (DWT).
Results: A total of 122 patients were enrolled. The mean age of the patients was 72 ± 13 years. The mean
total score, voiding subscore, and storage subscore of IPSS, and OABSS were 16.8 ± 7.3, 7.2 ± 4.8, 9.7 ± 3.4,
and 9.8 ± 3.1, respectively. Total score, voiding subscore, and storage subscore of IPSS were all negatively
correlated with catheter-free maximum and average ﬂow rate. Furthermore, storage subscore of IPSS was
negatively correlated with cystometric capacity, and positively correlated with postvoid residual urine.
OABSS was negatively correlated with cystometric capacity and catheter-free maximum ﬂow rate. In
bladder outlet obstruction (BOO) patients, total score and storage subscore of IPSS and OABSS were
positively correlated with IPP. There was no correlation between symptom scores and other urodynamic
parameters, prostate volume, and DWT.
Conclusion: In elderly male patients with non-neurogenic OAB, more severe storage symptoms are
associated with a lower maximum ﬂow rate and a more prominent IPP, indicating that a signiﬁcant cause
of male non-neurogenic OAB is prostate associated.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
According to the International Continence Society, overactive
bladder (OAB) is a syndrome of storage symptoms deﬁned as ur-
gency, with or without urge incontinence, usually associated with
daytime frequency and nocturia.1,2 The European Prospectivey, Taipei Veterans General
District, Taipei 11217, Taiwan.
ociation. Published by Elsevier TaInvestigation into Cancer and Nutrition study, a population-based
cross-sectional study, reported that the overall prevalence of OAB
is 11.8%.3 The recent OAB on Physical and Occupational Limitations
study in the United States reported that the prevalence of OAB was
16.4% and 30.0% among men and women, which increased with
advanced age.4
Blaivas et al5 suggested that most men with OAB also have
coexisting urological problems. Their data showed that the most
common diagnoses were benign prostatic enlargement (32%),
bladder outlet obstruction (BOO; 22%), and complications following
prostate cancer treatment (20%). Idiopathic OAB was diagnosed in
only 5% of their study population. Furthermore, between 46% andiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Patient demographics.
Mean ± standard deviation
Age (y) 72 ± 13
Free Qmean (mL/s) 7.4 ± 5.0
Free Qmax (mL/s) 14.7 ± 9.5
Cystometric capacity (mL) 176.4 ± 119.9
BOOI 45.4 ± 34.3
Prostate volume (mL) 39.1 ± 20.1
IPP (cm) 0.66 ± 0.51
DWT (cm) 0.22 ± 0.07
BOOI ¼ Bladder Outlet Obstruction Index; DWT ¼ detrusor wall thickness;
IPP ¼ intravesical prostatic protrusion; Qmax ¼ maximum ﬂow rate; Qmean ¼ mean
ﬂow rate.
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diagnosed with detrusor overactivity.6,7
A previous study had proved that intravesical prostatic protru-
sion (IPP) was a signiﬁcant predictor of BOO.8 By contrast, storage
symptoms could be secondary to BOO. Thus, it is valuable to know
whether there is a signiﬁcant correlation between IPP and storage
symptoms in male OAB patients. In this study, we investigated the
correlation between the subjective symptom score and objective
parameters of urodynamic and imaging studies in male patients
with non-neurogenic OAB.
2. Materials and methods
We prospectively recruited male patients with OAB symptoms
from our urology outpatient clinic between January 2008 and
June 2012. The study protocol was reviewed in advance by the
Ethics Committee of our hospital before any patients were
recruited. Informed consent was obtained from each patient prior
to participation in this study. All patients were interviewed to
obtain detailed personal and medical histories. Patients with
overt neurological disorders (e.g., spinal cord pathology) were
excluded.
Symptom severity was evaluated before medical treatment
(including treatment with antimuscarinic agent, a-blocker, or 5a-
reductase inhibitor) or surgery using the International Prostate
Symptom Score (IPSS) and Overactive Bladder Symptom Score
(OABSS) questionnaires. The IPSS questionnaire consists of seven
questions, each rated on a severity scale of 0e5. The summed scores
of each of the questions were the total score (IPSS-T). A subtotal
score for Question 1 (incomplete emptying), Question 3 (inter-
mittency), Question 5 (weak stream), and Question 6 (straining)
was designated as the “voiding symptom score (IPSS-V).” A subtotal
score for Question 2 (voiding frequency), Question 4 (voiding
urgency), and Question 7 (nocturia) was designated as the “storage
symptom score (IPSS-S).” Scores of 0e7, 8e19, and 20e35 represent
mild, moderate, and severe lower urinary tract symptoms,
respectively. The OABSS is a four-item questionnaire developed to
evaluate OAB symptoms. The maximal scores are 2, 3, 5, and 5 for
daytime frequency, nighttime frequency, urgency, and urgency in-
continence, respectively.
All patients underwent catheter-free uroﬂowmetry, postvoid
residual (PVR) urine measurement, and urodynamic pressure-ﬂow
studies. Bladder Outlet Obstruction Index (BOOI) was calculated
using the following formula: pressure at maximum ﬂow (PdetQmax)
e 2  maximum ﬂow rate (Qmax). Male BOO was deﬁned as
BOOI >40.9
All patients received transabdominal sonography, which pro-
vided information on prostate volume, IPP,8,10 and detrusor wall
thickness (DWT).11 The prostate volume was calculated using the
ellipsoid formula method (0.52  width  height  depth of the
prostate). IPP and DWT were measured under the bladder volume
of 150e200 mL.12 IPP was deﬁned as the vertical distance between
the tip of prostate protrusion and the bladder base, and was graded
as follows: Grade 1, 5 mm; Grade 2, >5e10 mm; and Grade 3,
>10 mm.8 DWT was deﬁned as the hypoechogenic distance
between the bladder mucosa and adventitia at the anterior bladder
wall.11
A p value < 0.05 was considered statistically signiﬁcant.
Spearman correlation coefﬁcient was carried out to determine the
correlations between subjective symptom score and objective
urodynamic parameters. These patients were further divided into
the BOO and non-BOO groups. Correlation between symptom score
and image parameter was carried out. Statistical analyses were
performed using SPSS 15.0 statistical software (SPSS Inc., Chicago,
IL, USA).3. Results
The mean age of the patients was 72 ± 13 years. Among these
patients, 102 (83.6%) patients were >60 years of age and 114 (93.4%)
patients were>50 years of age. Themean-free Qmean and Qmax were
7.4 mL/s and 14.7 mL/s, respectively (Table 1). The mean cysto-
metric capacity was 176.4 ± 120 mL and the mean PVR urine
measurement was 59.5 ± 93.9 mL. The average BOOI was 45.4
and the prevalence of BOO in male patients with OAB was 51.6%.
The mean prostate volume was 39.1 ± 20.1 cm3. The mean IPSS-T,
IPSS-V, and IPSS-S were 16.8 ± 7.3, 7.2 ± 4.8, and 9.7 ± 3.4,
respectively. Furthermore, 12 (9.8%) patients had mild, 69 (56.6%)
patients had moderate, and 41 (33.6%) patients had severe lower
urinary tract symptoms. The mean OABSS was 9.8 ± 3.1.
3.1. Correlation between symptom score and catheter-free
uroﬂowmetry
IPSS-T, IPSS-V, and IPSS-S were all negatively correlated with
catheter-free average (free Qmean) and maximum ﬂow rate (free
Qmax; Table 2). Nevertheless, OABSS was negatively correlated with
free Qmax only.
3.2. Correlation between symptom score and pressure-ﬂow study
IPSS-S was correlated with cystometric capacity and PVR urine
measurement. OABSS was correlated with cystometric capacity
alone. There was no correlation between IPSS-T, IPSS-V, and the
parameters of pressure-ﬂow study (Table 3).
3.3. Correlation between symptom score and image parameters in
BOO patients
IPSS-T, IPSS-S, and OABSS were correlated with IPP in BOO
patients. Nevertheless, IPSS-V was not correlated with image
parameters, including prostate volume, IPP, and DWT (Table 4).
4. Discussion
OAB symptoms are common and troublesome among the lower
urinary tract symptoms and often cause patients to seek medical
treatment. In men aged > 40 years, the prevalence of OAB is
15e60%.13 The rate increases to 80% in men over the age of 80
years.14 The pathophysiology of OAB is complicated and detrusor
hyperactivity is thought to be the most common cause of OAB
symptoms.15 In male patients, there are many conditions that could
contribute to OAB symptoms,16 and age and BOO are independently
associated with detrusor overactivity in patients with benign
prostate hyperplasia.5,17 Elderly patients formed themajority of our
study population (83.6% are aged > 60 years). In addition, elderly
Table 2
Correlation between symptom score and catheter-free uroﬂowmetry.
Correlation coefﬁcient
Free Qmean Free Qmax
IPSS-T 0.329 * 0.286 *
IPSS-V 0.302 * 0.238 *
IPSS-S 0.227 * 0.246 *
OABSS 0.174 0.185 *
*p < 0.05.
IPSS ¼ International Prostate Symptom Score; IPSS-S ¼ IPSS-storage symptom
score; IPSS-T ¼ IPSS-total score; IPSS-V ¼ IPSS-voiding symptom score; OABSS ¼
Overactive Bladder Symptom Score; Qmax ¼maximum ﬂow rate; Qmean¼mean ﬂow
rate.
Table 3
Correlation between symptom score and pressure-ﬂow study.
Correlation coefﬁcient
Cystometric capacity PdetQmax PVR BOOI
IPSS-T 0.013 0.029 0.089 0.064
IPSS-V 0.152 0.054 0.041 0.092
IPSS-S 0.195 * 0.002 0.178 * 0.006
OABSS 0.259 * 0.024 0.081 0.011
*p < 0.05.
BOOI ¼ Bladder Outlet Obstruction Index; IPSS ¼ International Prostate Symptom
Score; IPSS-S ¼ IPSS-storage symptom score; IPSS-T ¼ IPSS-total score; IPSS-V ¼
IPSS-voiding symptom score; OABSS¼Overactive Bladder Symptom Score; PdetQmax
¼ pressure at maximum ﬂow; PVR ¼ postvoid residual.
Table 4
Correlation between symptom score and image parameters in BOO patients.
Correlation coefﬁcient
Prostate volume IPP DWT
IPSS-T 0.128 0.288 * 0.212
IPSS-V 0.122 0.222 0.157
IPSS-S 0.064 0.296 * 0.173
OABSS 0.227 0.294 * 0.194
*p < 0.05.
BOO ¼ bladder outlet obstruction; DWT ¼ detrusor wall thickness;
IPP ¼ intravesical prostatic protrusion; IPSS ¼ International Prostate Symptom
Score; IPSS-S ¼ IPSS-storage symptom score; IPSS-T ¼ IPSS-total score; IPSS-V ¼
IPSS-voiding symptom score; OABSS ¼ Overactive Bladder Symptom Score.
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or benign prostate obstruction, compared with the general
population.14
In this study, these non-neurogenic OAB patients had low
average Qmean and Qmax. Furthermore, 63 patients (51.6%) were
diagnosed with BOO by the pressure-ﬂow study. Oelke et al11
proved that male patients with BOO have signiﬁcantly lower
Qmean and Qmax, compared with non-BOO patients, and Qmax 
15mL/s exhibited the highest negative predictive value (97%).11 In a
study of differential diagnosis of male OAB patients, Blaivas et al5
reported that 54% were diagnosed with benign prostate enlarge-
ment or benign prostate obstruction. In this study, low Qmean and
Qmax may be caused by prostate-associated BOO.
Our study conﬁrmed that storage symptom scores, including
IPSS-S and OABSS, were negatively correlated with cystometric
capacity. In addition, IPSS-S was positively correlated with PVR
urine measurement. Kim et al18 found that patients with OAB had a
premature ﬁlling sensation and decreased bladder capacity
compared with the normal population.18 Ho et al19 reported that
female OAB patients exhibited increased bladder sensation with
smaller bladder volume at the ﬁrst desire to void and larger PVR
urine measurement compared with non-OAB patients. Al-Zahraniand Gajewski20 reviewed 668 urodynamic study reports of OAB
patients and found that nocturia and frequency correlated inversely
with cystometric capacity. In summary, smaller bladder capacity
and larger PVR urine measurement might play an important role in
storage symptoms.
Storage symptom scores, including IPSS-S and OABSS, were
positively correlated with IPP in this study. IPP has already been
established as a statistically signiﬁcant predictor of BOO by Dr Foo
and colleagues.8,21 A higher IPP grade is associated with a higher
risk of progression in benign prostate enlargement.10 Moon et al22
proved that IPP exceeding 5.5 mm is signiﬁcantly associated with
BOO. Furthermore, IPP is correlated with the presence of detrusor
overactivity.23 Lee et al24 reported a signiﬁcant correlation between
the storage symptom score and IPP. Kim and Kim25 conﬁrmed that
male OAB symptoms were correlated with IPP. IPP represents the
medial and lateral lobes of the prostate protruding into the bladder,
causing obstruction and increased urethral resistance. Styles et al26
thought that detrusor overactivity was one of the manifestations of
impaired detrusor resulting from increased detrusor pressure
caused by the IPP. Consequently, male non-neurogenic OAB most
likely originated from prostate-associated BOO.
DWT is also a proven noninvasive predictor of BOO, and DWT
>2 mm is prone to BOO.11 Franco et al27 observed that DWT and IPP
were associated with bladder prostatic obstruction. Although IPP
was correlated with storage symptoms in our study, there was no
correlation between storage symptoms score and DWT. Blatt et al28
noted that DWTs of normal individuals were not different from
those of patients with detrusor overactivity or increased bladder
sensation. They also found that there was no signiﬁcant difference
in DWT between patients with BOO and those without.
This study has a number of limitations, which should be
considered. First, our sample size was relatively small and a larger
sample size may provide greater statistical strength. Second, as we
know, age is also another important factor for OAB. Further
age-stratiﬁed study may provide additional information.
In elderly male patients with non-neurogenic OAB, more severe
storage symptoms are associated with a lower maximum ﬂow rate
and a more prominent IPP. The results indicate that the cause of
non-neurogenic male OAB is most likely prostate associated.
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